Lucentis and Oa - a phase IV clinical study of FDA data

Summary:

Oa is reported as a side effect among people who take Lucentis (ranibizumab), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Avastin, and have Muscle spasms.

The phase IV clinical study analyzes which people have Oa when taking Lucentis. It is created by eHealthMe based on reports of 25,577 people who have side effects when taking Lucentis from the FDA, and is updated regularly.

What is Lucentis?

Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.

What is Oa?

Oa (osteoarthritis /a joint disease caused by cartilage loss in a joint) is found to be associated with 1,904 drugs and 2,624 conditions by eHealthMe. Check the latest studies of Oa.

On Nov, 12, 2025

25,577 people reported to have side effects when taking Lucentis.
Among them, 32 people (0.13%) have Oa.

Among these 32 people:

How long have people been on Lucentis when they have Oa? *

What is the gender of people who have Oa when taking Lucentis? *

female: 56.25 %
male: 43.75 %

What is the age of people who have Oa when taking Lucentis? *

What are other drugs people take besides Lucentis? *

What are other side effects people have besides Oa? *

Pain: 14 people, 43.75%
Cataract (clouding of the lens inside the eye): 14 people, 43.75%
Glaucoma (increased fluid pressure in the eye with vision loss): 13 people, 40.62%
Dyspnea (difficult or laboured breathing): 12 people, 37.50%
Visual Impairment: 12 people, 37.50%
Pain In Extremity: 12 people, 37.50%
Back Pain: 12 people, 37.50%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 11 people, 34.38%
Pneumonia: 11 people, 34.38%
Stress And Anxiety: 11 people, 34.38%

What are the existing conditions these people have? *

Toothaches (tooth pain): 8 people, 25.00%
Muscle Spasms (muscle contraction): 8 people, 25.00%
Depression: 4 people, 12.50%
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 3 people, 9.38%
Bone Neoplasm Malignant (cancer of bone): 3 people, 9.38%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 3 people, 9.38%
Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 9.38%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 3 people, 9.38%
Pain: 3 people, 9.38%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 9.38%

* Approximation only. Some reports may have incomplete information.

Do you take Lucentis and have Oa?

- Check whether Oa is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lucentis:

Lucentis (25,647 reports)

Oa treatments and more:

Oa (95,646 reports)

Browse all side effects of Lucentis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oa:

Oa (1,904 drugs)

Browse all the conditions that are associated with Oa:

Oa (2,624 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ranibizumab (the active ingredients of Lucentis) and Lucentis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.